Daniel J. Blanchard

An experienced member of the Firm’s Corporate Practice Group, Dan’s practice is focused on guiding his clients, which range from emerging and middle-market companies to family businesses and entrepreneurs, through corporate governance, employment matters, strategic commercial transactions, equity and debt fundraising activities, and mergers and acquisitions. Dan’s mergers and acquisitions practice focuses primarily on the technology and life sciences industries.

Dan advises lower to mid-market private equity funds and family offices in connection with their investments, the management of portfolio companies and leveraged “roll-up” transactions. He also represents lenders in complex finance transactions, including senior, second lien, venture debt financings and mezzanine financings, on an asset-based, recurring revenue and cash–flow basis.

Dan is a member of the Firm’s Corporate, M&A, VC, and Commercial Debt Financing practices. Prior to joining Morse, he was Of Counsel in the corporate group of an international law firm.

Affiliations

Boston Bar Association

American Bar Association

Speaking Engagements

Panelist, The DealMakers Virtual Event, 2020

Panelist, BIOTECH: Preparing for a Liquidity Event – Exit or IPO?

Publications

Capital Formation Reform, The Review of Securities & Commodities Regulation (December 21, 2011)

Outside the office

In his leisure time, Dan enjoys playing board games with his wife, Nicole, his son, Max, and his daughter, Isabelle. He is also an enthusiastic artisan bread baker, and stays current on world events by regularly reading The Economist.

News & Events

News

• Morse Ranked in 18 Categories in 2023 PitchBook League Tables
  March 5, 2024
• 2023 VC Deals
  A Snapshot of Venture Capital Transactions
  February 21, 2024
• 2019-2023 M&A Deals
  Mergers & Acquisitions: A Transaction Recap
  February 21, 2024
• Morse Ranked in 14 Categories in 2022 PitchBook League Tables
  March 29, 2023
• 2022 M&A Deals
  Mergers & Acquisitions: A Transaction Recap
  March 24, 2023

Events

• 2019 VC and M&A Forum
  May 2, 2019
• Corporate Venture Capital: Unique Opportunities and Special Considerations for Startup Companies
  May 3, 2018

Representative Matters

• Represented a pharmaceutical company in a $25 million joint venture transaction with a contract research organization.
• Represented a manufacturing company in a $2.5 million strategic acquisition of a luxury towel brand.
• Represented a car dealership conglomerate in multiple dealership acquisitions and dispositions for aggregate considerations ranging from under $1 million to over $5 million per transaction.
• Represented a venture capital-backed technology company in a $5 million strategic acquisition of specialized social media platform.
• Represented a global private equity and alternative assets investment firm in miscellaneous subscription credit facilities and portfolio company loans.
• Represented a SBIC fund in miscellaneous ABL Credit facilities supporting portfolio company roll-up transactions with various sponsor relationships.